Identification and quantification of the major volatile constituents in antidepressant active fraction of xiaoyaosan by gas chromatography–mass spectrometry-Reference-Cited by-同舟云学术

Identification and quantification of the major volatile constituents in antidepressant active fraction of xiaoyaosan by gas chromatography–mass spectrometry

Published:2012-05 Issue:1 Volume:141 Page:187-192
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Zhou Yuzhi,Ren Yanling,Ma Zhijie,Jia Guangcheng,Gao Xiaoxia,Zhang Lizeng,Qin Xuemei

Funder

National Natural Science Foundation of China

Programs of International Science and Technology Cooperation of China

Programs of Science and Technology of Shanxi Province

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference16 articles.

1. Is the forced swimming test a suitable model for revealing antidepressant activity?;Borsini;Psychopharmacology,1998

2. Platelets, fatty acids, depression and cardiovascular ischemic pathology;Cocchi;Progress in Nutrition,2007

3. Metabolomics study on the anti-depression effect of xiaoyaosan on rat model of chronic unpredictable mild stress;Dai;Journal of Ethnopharmacology,2010

4. Identification and quantification of 13 components in Angelica sinensis (Danggui) by gas chromatography–mass spectrometry coupled with pressurized liquid extraction;Lao;Analytica Chimica Acta,2004

5. Analysis of the fatty acid from Bupleurum Chinense DC in China by GC–MS and GC-FID;Li;Chemical and Pharmaceutical Bulletin,2005

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Xiaoyaosan promotes neurotransmitter transmission and alleviates CUMS-induced depression by regulating the expression of Oct1 and Oct3 in astrocytes of the prefrontal cortex;Journal of Ethnopharmacology;2024-05

2. Stable Isotope Tracer Technique and Network Pharmacology to Reveal Antidepressant Targets and Active Components of Xiaoyao San;Chemistry & Biodiversity;2024-03-27

3. The antitumor properties of atractylenolides: Molecular mechanisms and signaling pathways;Biomedicine & Pharmacotherapy;2022-11

4. Atractylenolides (I, II, and III): a review of their pharmacology and pharmacokinetics;Archives of Pharmacal Research;2021-07

5. Antidepressant‑like effects of Z‑ligustilide on chronic unpredictable mild stress‑induced depression in rats;Experimental and Therapeutic Medicine;2021-04-25